{
  "input": {
    "mode": "execute_actions",
    "query": {
      "entity": "Familial tumour syndromes of the central and peripheral nervous system",
      "relation": "contraindication"
    },
    "items": [
      {
        "hypothesis_id": "H1",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "不良反应风险",
            "expectation": "若Cyclophosphamide确实存在较大风险，则需标注高权重refutes边",
            "assignee": "Skeptic"
          }
        ]
      },
      {
        "hypothesis_id": "H2",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "不良反应风险",
            "expectation": "若Doxorubicin确实存在较大风险，则需标注高权重refutes边",
            "assignee": "Skeptic"
          }
        ]
      },
      {
        "hypothesis_id": "H3",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "不良反应风险",
            "expectation": "若Temozolomide确实存在较大风险，则需标注高权重refutes边",
            "assignee": "Skeptic"
          }
        ]
      },
      {
        "hypothesis_id": "H4",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "不良反应风险",
            "expectation": "若Vincristine确实存在较大风险，则需标注高权重refutes边",
            "assignee": "Skeptic"
          }
        ]
      },
      {
        "hypothesis_id": "H5",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "不良反应风险",
            "expectation": "若Etoposide确实存在较大风险，则需标注高权重refutes边",
            "assignee": "Skeptic"
          }
        ]
      },
      {
        "hypothesis_id": "H6",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "不良反应风险",
            "expectation": "若Bleomycin确实存在较大风险，则需标注高权重refutes边",
            "assignee": "Skeptic"
          }
        ]
      },
      {
        "hypothesis_id": "H7",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "不良反应风险",
            "expectation": "若Ifosfamide确实存在较大风险，则需标注高权重refutes边",
            "assignee": "Skeptic"
          }
        ]
      },
      {
        "hypothesis_id": "H8",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "不良反应风险",
            "expectation": "若Nitrosoureas确实存在较大风险，则需标注高权重refutes边",
            "assignee": "Skeptic"
          }
        ]
      },
      {
        "hypothesis_id": "H9",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "不良反应风险",
            "expectation": "若Methotrexate确实存在较大风险，则需标注高权重refutes边",
            "assignee": "Skeptic"
          }
        ]
      },
      {
        "hypothesis_id": "H10",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "不良反应风险",
            "expectation": "若Procarbazine确实存在较大风险，则需标注高权重refutes边",
            "assignee": "Skeptic"
          }
        ]
      },
      {
        "hypothesis_id": "H11",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "不良反应风险",
            "expectation": "若Bortezomib确实存在较大风险，则需标注高权重refutes边",
            "assignee": "Skeptic"
          }
        ]
      },
      {
        "hypothesis_id": "H12",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "不良反应风险",
            "expectation": "若Thalidomide确实存在较大风险，则需标注高权重refutes边",
            "assignee": "Skeptic"
          }
        ]
      }
    ],
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "n_target1",
          "type": "Target",
          "label": "DNA",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_target2",
          "type": "Target",
          "label": "Topoisomerase II",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_pathway1",
          "type": "Pathway",
          "label": "Apoptosis Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_pathway2",
          "type": "Pathway",
          "label": "Cell Cycle Arrest Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_disease",
          "type": "Disease",
          "label": "Familial Tumour Syndromes",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ph1",
          "type": "Phenotype",
          "label": "Tumor Growth",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ph2",
          "type": "Phenotype",
          "label": "Neurotoxicity",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_cyclophosphamide",
          "type": "Drug",
          "label": "Cyclophosphamide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_doxorubicin",
          "type": "Drug",
          "label": "Doxorubicin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_temozolomide",
          "type": "Drug",
          "label": "Temozolomide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_vincristine",
          "type": "Drug",
          "label": "Vincristine",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_etoposide",
          "type": "Drug",
          "label": "Etoposide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_bleomycin",
          "type": "Drug",
          "label": "Bleomycin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ifosfamide",
          "type": "Drug",
          "label": "Ifosfamide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_nitrosoureas",
          "type": "Drug",
          "label": "Nitrosoureas",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_methotrexate",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_procarbazine",
          "type": "Drug",
          "label": "Procarbazine",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_bortezomib",
          "type": "Drug",
          "label": "Bortezomib",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_thalidomide",
          "type": "Drug",
          "label": "Thalidomide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot",
          "type": "Target",
          "label": "OffTarget",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp",
          "type": "Pathway",
          "label": "Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_advPhenotype",
          "type": "Phenotype",
          "label": "Adverse Phenotype",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "H1",
          "type": "Hypothesis",
          "label": "Cyclophosphamide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_cyclophosphamide",
          "type": "Drug",
          "label": "Cyclophosphamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H2",
          "type": "Hypothesis",
          "label": "Doxorubicin",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_doxorubicin",
          "type": "Drug",
          "label": "Doxorubicin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H3",
          "type": "Hypothesis",
          "label": "Temozolomide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_temozolomide",
          "type": "Drug",
          "label": "Temozolomide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H4",
          "type": "Hypothesis",
          "label": "Vincristine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_vincristine",
          "type": "Drug",
          "label": "Vincristine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H5",
          "type": "Hypothesis",
          "label": "Etoposide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_etoposide",
          "type": "Drug",
          "label": "Etoposide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H6",
          "type": "Hypothesis",
          "label": "Bleomycin",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_bleomycin",
          "type": "Drug",
          "label": "Bleomycin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H7",
          "type": "Hypothesis",
          "label": "Ifosfamide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_ifosfamide",
          "type": "Drug",
          "label": "Ifosfamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H8",
          "type": "Hypothesis",
          "label": "Nitrosoureas",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_nitrosoureas",
          "type": "Drug",
          "label": "Nitrosoureas",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H9",
          "type": "Hypothesis",
          "label": "Methotrexate",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_methotrexate",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H10",
          "type": "Hypothesis",
          "label": "Procarbazine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_procarbazine",
          "type": "Drug",
          "label": "Procarbazine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H11",
          "type": "Hypothesis",
          "label": "Bortezomib",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_bortezomib",
          "type": "Drug",
          "label": "Bortezomib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H12",
          "type": "Hypothesis",
          "label": "Thalidomide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_thalidomide",
          "type": "Drug",
          "label": "Thalidomide",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_cyclophosphamide",
          "target": "n_target1",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "已知氮芥类药物作用于DNA"
        },
        {
          "source": "drug_doxorubicin",
          "target": "n_target2",
          "relation": "acts_on",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "已有实验证据支持其与拓扑异构酶 II 结合"
        },
        {
          "source": "n_target1",
          "target": "n_pathway1",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "DNA损伤通路与细胞凋亡密切相关"
        },
        {
          "source": "n_target2",
          "target": "n_pathway2",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "拓扑异构酶 II 在细胞周期调控中起重要作用"
        },
        {
          "source": "n_pathway1",
          "target": "n_ph1",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "细胞凋亡直接导致肿瘤生长抑制"
        },
        {
          "source": "n_pathway2",
          "target": "n_ph2",
          "relation": "causes",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "细胞周期停滞可引发神经毒性"
        },
        {
          "source": "drug_temozolomide",
          "target": "n_target1",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "常用于胶质瘤的DNA烷化剂"
        },
        {
          "source": "drug_vincristine",
          "target": "n_pathway2",
          "relation": "modulates",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "已知抑制微管聚合引起细胞周期停滞"
        },
        {
          "source": "drug_etoposide",
          "target": "n_target2",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "靶向拓扑异构酶 II 的经典药物"
        },
        {
          "source": "drug_bleomycin",
          "target": "n_target1",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "已知导致DNA单链断裂"
        },
        {
          "source": "drug_ifosfamide",
          "target": "n_target1",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "类似于环磷酰胺，影响DNA"
        },
        {
          "source": "drug_nitrosoureas",
          "target": "n_target1",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "常用于脑肿瘤治疗的药物"
        },
        {
          "source": "drug_methotrexate",
          "target": "n_ph2",
          "relation": "modulates",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "已知与神经系统相关的副作用"
        },
        {
          "source": "drug_procarbazine",
          "target": "n_ph1",
          "relation": "causes",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "与肿瘤生长相关临床发现"
        },
        {
          "source": "drug_bortezomib",
          "target": "n_pathway1",
          "relation": "modulates",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "已知影响凋亡通路"
        },
        {
          "source": "drug_thalidomide",
          "target": "n_ph2",
          "relation": "causes",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "可能导致神经毒性"
        },
        {
          "source": "drug_cyclophosphamide",
          "target": "H1",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "机制支持对肿瘤的影响"
        },
        {
          "source": "drug_doxorubicin",
          "target": "H2",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "对特定肿瘤类型有效的已知反应"
        },
        {
          "source": "drug_temozolomide",
          "target": "H3",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "对胶质瘤的有效性已知"
        },
        {
          "source": "drug_vincristine",
          "target": "H4",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "与细胞周期影响相关已知"
        },
        {
          "source": "drug_etoposide",
          "target": "H5",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "与细胞周期及肿瘤抑制作用相关"
        },
        {
          "source": "drug_bleomycin",
          "target": "H6",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "与重要的DNA损伤机制相关"
        },
        {
          "source": "drug_ifosfamide",
          "target": "H7",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "剽窃与环磷酰胺的药理关联"
        },
        {
          "source": "drug_nitrosoureas",
          "target": "H8",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "与类似肿瘤治疗药物响应一致"
        },
        {
          "source": "drug_methotrexate",
          "target": "H9",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "与潜在的神经影响有关"
        },
        {
          "source": "drug_procarbazine",
          "target": "H10",
          "relation": "supports",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "与预期肿瘤干预相关"
        },
        {
          "source": "drug_bortezomib",
          "target": "H11",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "可能涉及不同的机制"
        },
        {
          "source": "drug_thalidomide",
          "target": "H12",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "相关的潜在风险与神经影响"
        },
        {
          "source": "n_cyclophosphamide",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能作用于非靶点，引发风险"
        },
        {
          "source": "n_doxorubicin",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能作用于非靶点，引发风险"
        },
        {
          "source": "n_temozolomide",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能作用于非靶点，引发风险"
        },
        {
          "source": "n_vincristine",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能作用于非靶点，引发风险"
        },
        {
          "source": "n_etoposide",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能作用于非靶点，引发风险"
        },
        {
          "source": "n_bleomycin",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能作用于非靶点，引发风险"
        },
        {
          "source": "n_ifosfamide",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "可能作用于非靶点，引发风险"
        },
        {
          "source": "n_nitrosoureas",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "可能作用于非靶点，引发风险"
        },
        {
          "source": "n_methotrexate",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.5,
          "agent": "Skeptic",
          "rationale": "可能作用于非靶点，引发风险"
        },
        {
          "source": "n_procarbazine",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.5,
          "agent": "Skeptic",
          "rationale": "可能作用于非靶点，引发风险"
        },
        {
          "source": "n_bortezomib",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.5,
          "agent": "Skeptic",
          "rationale": "可能作用于非靶点，引发风险"
        },
        {
          "source": "n_thalidomide",
          "target": "n_ot",
          "relation": "acts_on",
          "weight": 0.5,
          "agent": "Skeptic",
          "rationale": "可能作用于非靶点，引发风险"
        },
        {
          "source": "n_ot",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "引发相关风险通路"
        },
        {
          "source": "n_rp",
          "target": "n_advPhenotype",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "导致不良反应"
        },
        {
          "source": "n_advPhenotype",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消 Cyclophosphamide 的净获益"
        },
        {
          "source": "n_advPhenotype",
          "target": "H2",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消 Doxorubicin 的净获益"
        },
        {
          "source": "n_advPhenotype",
          "target": "H3",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消 Temozolomide 的净获益"
        },
        {
          "source": "n_advPhenotype",
          "target": "H4",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消 Vincristine 的净获益"
        },
        {
          "source": "n_advPhenotype",
          "target": "H5",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消 Etoposide 的净获益"
        },
        {
          "source": "n_advPhenotype",
          "target": "H6",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消 Bleomycin 的净获益"
        },
        {
          "source": "n_advPhenotype",
          "target": "H7",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消 Ifosfamide 的净获益"
        },
        {
          "source": "n_advPhenotype",
          "target": "H8",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消 Nitrosoureas 的净获益"
        },
        {
          "source": "n_advPhenotype",
          "target": "H9",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消 Methotrexate 的净获益"
        },
        {
          "source": "n_advPhenotype",
          "target": "H10",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消 Procarbazine 的净获益"
        },
        {
          "source": "n_advPhenotype",
          "target": "H11",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消 Bortezomib 的净获益"
        },
        {
          "source": "n_advPhenotype",
          "target": "H12",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消 Thalidomide 的净获益"
        }
      ],
      "round_index": 2
    },
    "constraints": {
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "hypothesis_id": "H1",
    "executed_actions": [
      {
        "action_ref": 0,
        "status": "done",
        "graph_updates": {
          "add_nodes": [
            {
              "id": "n_ot",
              "type": "Target",
              "label": "OffTarget",
              "attrs": {
                "agent": "Skeptic"
              }
            },
            {
              "id": "n_rp",
              "type": "Pathway",
              "label": "Risk Pathway",
              "attrs": {
                "agent": "Skeptic"
              }
            },
            {
              "id": "n_advPhenotype",
              "type": "Phenotype",
              "label": "Adverse Phenotype",
              "attrs": {
                "agent": "Skeptic"
              }
            }
          ],
          "add_edges": [
            {
              "source": "n_cyclophosphamide",
              "target": "n_ot",
              "relation": "acts_on",
              "weight": 0.8,
              "agent": "Skeptic",
              "rationale": "可能作用于非靶点，引发风险"
            },
            {
              "source": "n_ot",
              "target": "n_rp",
              "relation": "involved_in",
              "weight": 0.8,
              "agent": "Skeptic",
              "rationale": "引发相关风险通路"
            },
            {
              "source": "n_rp",
              "target": "n_advPhenotype",
              "relation": "causes",
              "weight": 0.8,
              "agent": "Skeptic",
              "rationale": "导致不良反应"
            },
            {
              "source": "n_advPhenotype",
              "target": "H1",
              "relation": "refutes",
              "weight": 0.85,
              "agent": "Skeptic",
              "rationale": "若该风险成立，将抵消 Cyclophosphamide 的净获益"
            }
          ],
          "merge": [],
          "set_weights": [],
          "conflict_hotspots": []
        },
        "notes": "已完成安全性压力测试：Cyclophosphamide 的风险链已添加"
      }
    ],
    "unexecuted_actions": [],
    "residual_conflicts": []
  }
}